Previously, Wu et al. found active SLE patients had a significant increase in HLA-DR−CD11b+CD33+ MDSCs, including both CD14+CD66b− monocytic and CD14−CD66b+ granulocytic MDSCs in the peripheral blood as compared to healthy controls (24). Here, CD14 is linked to systemic lupus erythematosus.